EXAI - AI Drug Hunter Firm Exscientia Fires Its CEO Over 'Inappropriate' Relationships with Two Employees | Benzinga
Tuesday, Exscientia Plc (NASDAQ:EXAI) fired CEO Andrew Hopkins, effective immediately after the board determined he had engaged in two personal relationships with employees deemed “inappropriate and inconsistent” with company values.
Exscientia is an AI-driven precision medicine company focused on discovering, designing, and developing possible drugs fastest and most effectively.
Exscientia developed a functional precision oncology platform to guide treatment selection, improve patient outcomes in a prospective interventional clinical study, and progress AI-designed small molecules into the clinical setting.
A search is underway for his replacement, ...